Shortfall in Trial Recruitment Could Affect COVID-19 Vaccine Rollout
Reuters recently interviewed Ramod Rouhbakhsh, MD, with Hattiesburg Clinic MediSync®, to discuss the shortfall of minority recruitment in the Moderna vaccine trial and how that could affect the timeline of the COVID-19 vaccine rollout.
“It essentially was becoming first-come, first-served, and it was skewing towards not getting enough minorities,” said Dr. Rambod Rouhbakhsh, a lead researcher at the MediSync Clinical Research Hattiesburg Clinic in Petal, Mississippi, a commercial site hired by PPD for the Moderna trial.
Follow the link to read more about how the lack of minority volunteers could slow down the COVID-19 vaccine approval: https://reut.rs/3dsf8BJ
